Compare TransMedics Group Inc (TMDX) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? TransMedics Group Inc trades at $86.5 (market cap $3.00B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.73. Which is the better fit depends on your goals.
| TMDX | VTIP | |
|---|---|---|
Market Cap | $3.00B | — |
Sector | Technology | — |
52-Week High | $150.42 | $50.75 |
52-Week Low | $61.99 | $49.39 |
Enterprise Value | $3.39B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 results with $605M revenue and 31.4% net margin, though 2026 projections show margin compression. Recent news highlights growth initiatives in kidney transplantation and European markets, alongside ongoing legal investigations into fiduciary duties.
The stock offers upside to the $99.57 consensus price target, supported by analyst bullishness (69% buy ratings), but faces risks from margin pressure, legal scrutiny, and earnings misses. Revenue growth remains a key catalyst, though execution risks and investor sentiment headwinds warrant caution.
VTIP (Vanguard Short-Term Inflation-Protected Securities ETF) trades at $49.75 with minimal daily movement (+0.04%). Technical indicators show a bearish bias with moving averages signaling sell pressure, though oscillators remain neutral. The fund focuses on short-duration TIPS to hedge inflation with reduced interest-rate sensitivity. Recent news highlights its role as a low-cost inflation hedge amid persistent above-target inflation and multi-decade high real yields on long-term TIPS.
Outlook: VTIP offers a defensive allocation for inflation protection, but bearish technicals and flat performance (4% gain since June 2025 per ETF Trends) limit near-term upside. Risks include interest-rate volatility and inflation trajectory shifts. Institutional interest grew with 55 North Private Wealth increasing holdings by 12.2% in Q2 2026 (Defense World, Aug 2026).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
